← American Pharmacists Association (APhA)
CMSRulemakingCMS-2017-0156

Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs For Contract Year 2019 CMS-4182-P

RIN
—
Last modified
Nov 25, 2025
Comment window
closed 3115d ago
American Pharmacists Association (APhA) filings
1

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between Jan 18, 2018 and Jan 18, 2018. 131 other organizations filed here. The comment window closed 3115d ago.

What American Pharmacists Association (APhA) filed (1)

Jan 18, 2018· American Pharmacists Association--DC· CMS-2017-0156-1619

APhA is pleased to submit these comments regarding the proposed changes to the Part D program for CY 2019 (the "Proposed Rule"). APhA, founded in 1852 as the American Pharmaceutical Association, represents 64,000 pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians, and others interested in improving medication use and advancing patient care. APhA members provide care in all practice settings, including community pharmacies, physicians' offices, hospitals, long-term care facilities, community health centers, managed care organizations, hospice settings and the uniformed services. (See, attached .PDF for full comments). If you have any questions or require additional information, please contact Michael Baxter, Director of Regulatory Affairs, at mbaxter@aphanet.org or by phone at (202) 429-7538. Sincerely, Thomas E. Menighan, BSPharm, MBA, ScD (Hon), FAPhA Executive Vice President and CEO cc:Stacie S. Maass, RPh, JD, Senior Vice President, Pharmacy Practice and Government Affairs Anne Burns, Vice President, Professional Affairs

View on regulations.gov →

Abstract

N/A

View on regulations.gov →

Co-filers (131)

See everyone who commented →